125 related articles for article (PubMed ID: 37248101)
1. Association between epithelial-mesenchymal transition markers, proliferative index, and oral epithelial dysplasia: an immunohistochemical study.
Miguel AFP; Poletto DAG; Embaló B; Rivero ERC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):904-913. PubMed ID: 37248101
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
3. Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.
Novack R; Zhang L; Hoang LN; Kadhim M; Ng TL; Poh CF; Kevin Ko YC
Mod Pathol; 2023 Jul; 36(7):100153. PubMed ID: 36906072
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
[TBL] [Abstract][Full Text] [Related]
6. [The expression characteristics and clinical significance of candidate molecular markers in vocal cord leukoplakia].
Cui WX; Xu W; Yang QW; Li YR; Hu R; Cheng LY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):592-596. PubMed ID: 30121997
[No Abstract] [Full Text] [Related]
7. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
9. Association between p62 expression and clinicopathological characteristics in oral leukoplakia.
Yoshida T; Terabe T; Nagai H; Uchida F; Hasegawa S; Nagao T; Miyabe S; Ishibashi-Kanno N; Yamagata K; Warabi E; Gosho M; Yanagawa T; Bukawa H
Clin Exp Dent Res; 2019 Aug; 5(4):389-397. PubMed ID: 31452949
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia.
Sundberg J; Pandey S; Giglio D; Holmberg E; Kjeller G; Kovács A; Sand LP; Tokozlu B; Öhman J; Sapkota D; Hasséus B
Sci Rep; 2021 Oct; 11(1):20781. PubMed ID: 34675318
[TBL] [Abstract][Full Text] [Related]
11. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
13. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia.
Monteiro L; do Amaral B; Delgado L; Garcês F; Salazar F; Pacheco JJ; Lopes C; Warnakulasuriya S
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625534
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
16. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
17. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
18. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of MMP-9, TIMP-1, and Vimentin and its Correlation With Inflammatory Reaction and Clinical Parameters in Oral Epithelial Dysplasia.
Miguel AFP; Embaló B; Alves Dias HB; Rivero ERC
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):382-389. PubMed ID: 33587449
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin expression in oral leukoplakia: tumorigenic role.
de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
